MarketCapTrends
TECH

Bio-Techne Corporation (TECH)

NASDAQ · Healthcare

Bio-Techne Corporation annual/quarterly shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Bio-Techne Corporation shareholder equity for the quarter ending June 30, 2025 were 1.92B, a 7.25% decrease year-over-year.
  • Bio-Techne Corporation shareholder equity for 2025 were 1.92B, a 7.25% decrease from 2024.
  • Bio-Techne Corporation shareholder equity for 2024 were 2.07B, a 5.20% increase from 2023.
  • Bio-Techne Corporation shareholder equity for 2023 were 1.97B, a 15.56% increase from 2022.
  • Bio-Techne Corporation shareholder equity for 2022 were 1.70B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Bio-Techne Corporation Annual Shareholder Equity (Millions of US $)
2025$1,919
2024$2,069
2023$1,967
2022$1,702
2021$1,563
2020$1,381
2019$1,166
2018$1,079
2017$950
2016$879
2015$847
2014$795
2013$738
2012$674
2011$586
Bio-Techne Corporation Quarterly Shareholder Equity (Millions of US $)
2025-06-30$1,919
2024-06-30$2,069
2023-06-30$1,967
2022-06-30$1,702
2021-06-30$1,563
2020-06-30$1,381
2019-06-30$1,166
2018-06-30$1,079
2017-06-30$950
2016-06-30$879
2015-06-30$847
2014-06-30$795
2013-06-30$738
2012-06-30$674
2011-06-30$586
2010-06-30$502
2009-06-30$456

Bio-Techne Corporation Shareholder Equity — FAQ

Bio-Techne Corporation (TECH) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TECH's shareholder equity history?

The chart and table above show Bio-Techne Corporation's shareholder equity by year and by quarter, including the growth rate.